Viewing Study NCT02052193


Ignite Creation Date: 2025-12-25 @ 1:07 AM
Ignite Modification Date: 2026-02-22 @ 6:13 PM
Study NCT ID: NCT02052193
Status: TERMINATED
Last Update Posted: 2022-12-19
First Post: 2014-01-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of Photosensitivity in Dabrafenib or Vemurafenib Treated Metastatic Melanoma Patients - a Phase IIa/IIb Study
Sponsor: University Hospital Tuebingen
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Melanoma (Carrying BRAF V600 Mutation) View
Keywords: